Skip to main content

Table 4 Group differences of improvers and non-improvers in the FMA hand score

From: Long-term recovery of upper limb motor function and self-reported health: results from a multicenter observational study 1 year after discharge from rehabilitation

 

Total

(n = 50)

Improver

(n = 39)

Non-Improver

(n = 11)

p value

Demographic characteristics

 Female

12 (24)

6 (15)

6 (55)

0.0155

 Age

59 (53–67)

60 (50–65)

59 (56–74)

0.3187

Clinical characteristics

 Ischemic stroke

46 (92)

37 (95)

9 (82)

0.2069

 Baseline NIHSS

4 (2–6)

4 (1.5–6)

3 (2.25–4.75)

0.6984

 Baseline mRS

2 (1–2)

2 (1–2)

2 (1.5–2.5)

0.3416

Cardiovascular risk factors

 Hypertension

42 (84)

34 (87)

8 (73)

0.3533

 Hyperlipidemia

37 (77)

28 (76)

9 (82)

0.7136

 Diabetes mellitus

12 (24)

10 (26)

2 (18)

0.7351

 Atrial fibrillation

2 (5)

2 (7)

0 (0)

1

 Overweight

20 (40)

16 (41)

4 (36)

1

 Nicotine abuse

21 (43)

17 (44)

4 (40)

1

 Alcohol abuse

5 (10)

4 (10)

1 (9)

1

MoCA (at inclusion)

25 (22–27)

25 (23–27)

22 (20.5–24)

0.0252

IMET (at inclusion)

35 (24.75–52)

31 (22.5–51)

50 (35–52)

0.1805

PHQ4 (at inclusion)

3 (1–4)

2.5 (0.25–4)

3 (2–4)

0.6185

Motor therapy duration

46.7 (9–100.4)

48.3 (17.5–101.3)

26.7 (1.7–74.4)

0.3204

PROMIS-10 (at inclusion)

 Physical domain

42.3 (39.8–47.7)

42.3 (39.8–47.7)

42.3 (38.6–44.9)

0.6190

 Mental domain

43.5 (41.1–45.8)

43.5 (41.1–47.68)

41.1 (38.8–44.65)

0.1446

  1. NIHSS: National Institutes of Health Stroke Scale, mRS: modified Rankin Scale, MoCA: Montreal Cognitive Assessment, IMET: Index for the Assessment of Health Impairments, PHQ4: Patient Health Questionnaire-4, Motor therapy duration: Mean weekly minutes of physio- or ergotherapy across all follow-ups. Values are reported as numbers (percent) or median (interquartile range) where applicable. Significant p values are displayed in bold